Clinical Trial Update: Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ABT-414 (pacritinib? actually ABT-414 is depatuxizumab mafodotin) alone or with temozolomide versus lomustine or temozolomide for recur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• ABT-414 (depatuxizumab mafodotin)
• Lomustine (Lomustine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: AbbVie | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2020-05-22